HDAC9 and cancer: In addition to single agent activity, these inhibitors also act synergistically with other cancer therapeutic agents such as HDAC inhibitors [15, 16], mTOR inhibitors [13, 17, 18], and PI3K inhibitors [19] in inducing apoptosis and inhibiting the growth of cancer cells and tumors.